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Abstract
Non-invasive assay of the consumption and release of metabolites by individual human embryos could allow selection at
the cleavage stage of development and facilitate Single Embryo Transfer in clinical IVF but will require simple, high
throughput, sensitive methods applicable to small volume samples.
A rapid, simple, non-invasive method has therefore been devised using a standard fluorescence plate reader, and used to
measure the consumption of pyruvate and glucose, and release of lactate by single bovine embryos at all stages of
preimplantation development in culture; amino acid profiles have been determined using HPLC.
Early embryos with an ‘intermediate’ level (6.1460.27 pmol/embryo/h) of pyruvate uptake were associated with the
highest rate (68.3%) of blastocyst development indicating that a mid ‘‘optimum’’ range of pyruvate consumption correlates
with high viability in this bovine model.
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Introduction
There is a consensus move in clinical IVF towards single
embryo transfer (SET) in order to reduce the incidence of multiple
pregnancies. Elective SET is largely applied to blastocyst-stage
embryos, since these have higher implantation rates than those at
the cleavage stage [1]. However, despite the fact that embryo
culture conditions in vitro support early development successfully,
they are likely to be suboptimal compared to the in vivo
environment [2] and there is evidence that prolonged culture
may increase the risk of deleterious consequences [3] including
alteration of gene expression, particularly of imprinted genes [4–
6]. Identification of biomarkers of embryo viability early in
development, which complement morphological evaluation,
wouldt avoid the need to culture embryos until the blastocyst
stage. One possible route to discovering such a biomarker of
embryo viability lies in the study of early embryo metabolism,
much of the stimulus for which has been driven by the notion that
metabolic changes may be measured non-invasively and be
predictive of viability.
Mammalian preimplantation embryo metabolism follows a
widely accepted general pattern, which has been extensively
reviewed [7–9]. During the cleavage stages, early embryos
predominantly consume pyruvate, which is largely oxidised to
CO2 [10] but, at least in the human, may also be converted to
lactate [11]. Glucose depletion at this time is relatively low. At
cavitation, glucose consumption increases markedly, giving an
appearance of a ‘‘glycolytic phenotype’’ in vitro. However, the
major source of ATP generation continues to be via oxidative
phosphorylation, as demonstrated by a marked rise in O2
consumption at the blastocyst stage [12–14]. This general pattern
appears to operate in most mammalian species studied [9]. In
addition to glucose, lactate and pyruvate, amino acids may act as
an energy source as well as playing a variety of other metabolic
roles during preimplantation development [7]. A crucial discovery
of recent years has been the realization that endogenous stores can
also provide energy during early embryo development (for reviews,
see: [15,16].
A number of reports have proposed a link between metabolic
activity and embryo viability; for example, those of Conaghan et al
[17] for pyruvate, Houghton et al [14] for oxygen, Gardner and
Leese [18] and Gardner et al [19] for glucose and Houghton et al
[20] and Brison et al [21] for amino acids. However, the patterns
that link single metabolite markers with viability are contested,
with some reports proposing that low substrate consumption is
indicative of high viability [22] while others suggest the converse
[19]. Metabolomic approaches, which differ from studies of
metabolism by screening the whole repertoire of small molecules,
initially gave promising results for early embryo selection [23,24].
However, the patterns that link metabolism and viability using this
technology are not clear-cut and a recent prospective randomized
trial has shown that the metabolomic approach did not improve
the chance of IVF success and needed further development before
it could be used as an objective marker of embryo viability [25].
Thus, there is a need for a simple, high throughput method to
enable further investigations of embryo metabolism in a range of
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settings to build the knowledge set prior to possible translation of
metabolic selection of embryos into a clinical setting. However
progress toward this goal has been impeded by the need to use
methods that are technically demanding and require specialist
complex equipment in order to carry out metabolite assays on very
small volume samples (5 ml–10 ml) with sufficient sensitivity to
detect the metabolic activity of single preimplantation embryos.
In this paper, we have therefore refined and simplified the
non-invasive enzymatic determination of spent embryo culture
medium, based largely on the work of Leese and Barton [26],
for use in a modern fluorescence plate reader. In vitro produced
bovine embryos have been used as a model species. As well as
describing the technique, we have measured the depletion of
glucose and pyruvate, and the production of lactate on the same
cohort of embryos in individual culture throughout preimplan-
tation development and compared these results to established
equivalent data as a means of validating the method. In
addition, we have measured the depletion and appearance of a
mixture of amino acids by HPLC to generate a comprehensive
picture of metabolite consumption and release (CORE) by
embryos in vitro. Using this approach, we have been able to
relate metabolic activity to the ongoing developmental progress
of single embryos.
Materials and Methods
All chemicals were obtained from Sigma-Aldrich Chemical
(Poole, UK) unless otherwise indicated. All enzymes for metabolic
analysis were supplied by Roche (Burgess Hill, UK).
In vitro production of bovine embryos
Ovaries were collected from a local abattoir and transported in
Phosphate-Buffered Saline (PBS) at 39uC to the laboratory within
3 h of slaughter. Animal tissue was collected with full permission
from slaughterhouse (ABP, Murton, York, UK). Upon arrival in
the laboratory, the ovaries were washed twice with fresh warmed
PBS and maintained at 39uC until aspirated.
Production of bovine embryos was performed as described
previously [27]. Oocyte maturation was carried out in bicarbon-
ate-buffered TCM-199 supplemented with 10% fetal bovine
serum, 0.01 IU FSH/LH (Ferring Pharmaceutical, Langley,
UK), 0.40 mg epidermal growth factor ml21 and 2.2 ng fibroblast
growth factor ml21, in groups of 50 in 500 ml, incubated for 24 h
at 39uC under humidified 5% CO2 in air.
Mature oocytes were fertilized with spermatozoa prepared from
frozen-thawed semen samples from a single bull of proven fertility.
Motile spermatozoa were collected after centrifugation on a
discontinuous Percoll (Pharmacia Biotech, St Albans, UK)
gradient (45:90%) at 7606g for 30 min at room temperature.
Spermatozoa and oocyte cumulus complexes (OCCs) were co-
incubated in fertilization-TALP (Fert-TALP; [28]) for 18–24 h
under the same conditions as described for oocyte maturation.
At 18–24 h post-insemination, putative zygotes were placed in
groups of 20 in 20 ml droplets of a modified SOFaaBSA medium
without lactate, under mineral oil and incubated at 39uC in a
humidified atmosphere of 5% CO2, 5% O2 and 90% N2.
Determinations of the COnsumption of pyruvate and glucose,
and RElease of lactate as well as amino acid COnsumption and
Release (CORE analysis) were performed on two- to four-cell,
eight-cell embryos, morula, early blastocysts, expanded blastocysts
and hatched blastocysts stages (days 2, 3, 5, 6, 7 or 8 of culture,
respectively). Morphological assessment of blastocysts was based
on the expansion of the blastocoele cavity (B1 to B7) [29] B1–B2
stages were defined as early blastocysts, B3–B4 stages were defined
as expanded blastocysts, whereas B5–B7 stages were defined as
hatching/hatched blastocysts.
Individual culture of embryos for metabolic analysis
Embryos were moved from SOFaaBSA culture medium to
SOFaaBSA ‘‘analysis’’ medium, which contained 0.5 mmol
glucose l21 and no lactate, but was identical to SOFaaBSA in
all other respects. After two washes in SOFaaBSA ‘‘analysis’’
medium, embryos were incubated individually for 24 h in 4 ml
droplets of this medium under mineral oil at 39uC in a humidified
atmosphere of 5% CO2, 5% O2, 90% N2. Control droplets of
medium, incubated adjacent to the droplets containing the
embryos, were used as controls to account for non-specific
metabolite degradation/appearance. Samples were frozen under
oil at 280uC until analysis.
After 24 hours of culture, the morphological status of each
embryo was recorded and compared to the stage recorded at the
beginning of individual culture. Embryos with morphological
progression were defined as follows: increase in the number of cells
for cleaved embryos and progression towards a higher stage for
morula, early and expanded blastocyst (ie: morula to B1 for
morula, B1 to B2 for early blastocysts and B4 to B5 for expanded
blastocysts). By analyzing the difference between substrate levels in
incubation droplets and controls, measurements could be made on
individual embryos. In this way, a ‘CORE’ profile of individual
bovine embryo metabolism from day 2 to day 8 was produced.
Determination of pyruvate and glucose uptake and
lactate production
Analysis of the control and embryo samples of media was
performed with a TecanH Infinite M200 spectrophotometer using
an ultramicrofluorometric technique adapted from those of Leese
and Barton (26); Gardner and Leese [30] and Leese, [31]. This
modified method uses a 96-well plate system and enables the rapid
measurement of depletion or appearance of metabolites by a
number of individual embryos in parallel in a high throughput
manner. The assay mixtures (details below) were excited at
340 nm with emitted fluorescence measured at 460 nm to give a
background fluorescent value. Sample/control medium (1 ml) was
added to 10 ml of assay mixture and fluorescence recorded as
described above.. In this way, changes in fluorescence due to
NADH oxidation or NAD+/NADP+ reduction were recorded and
calibrated against a series of standards. All reagents and samples
were kept on ice, and reactions carried out at 25uC. Uptake or
production over the 24 h period were determined in triplicate
against a freshly prepared six point standard curve for each
compound and expressed as pmol/embryo/h. Results are
expressed as means 6 SEM. For each measure, the confirmed
variance of assay was ,5%.
Assays for pyruvate
Sample medium (1 ml) was added to 10 ml of assay mixture
containing 0.1 mM NADH and 40 IU lactate dehydogenase ml21
in 4.6 mM EPPS buffer, pH 8.0, and incubated at 25uC for
3 minutes. Changes in fluorescence due to NADH oxidation were
monitored. Final concentrations in each spent culture droplet were
determined against a six point standard curve from 0–0.45 mM
pyruvate.
Assays for glucose
Sample medium (1 ml) was added to 10 ml of assay mixture
containing 0.4 mM dithiothreitol, 3.07 mM MgSO4, 0.42 mM
ATP, 1.25 mM NADP+, 20 IU hexokinase/glucose-6-phosphate
Embryo Metabolism and Viability
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dehydrogenase (HK/G6PDH) ml21 in EPPS buffer at pH 8.0,
and incubated at 25uC for 10 minutes. Changes in fluorescence
due to NADP+ reduction were monitored. Final concentrations in
each spent culture droplet were determined against a six point
standard curve from 0–0.5 mM glucose.
Assays for lactate
Sample medium (1 ml) was added to 10 ml of assay mixture
containing 40 IU lactate dehydrogenase (LDH) ml21 in a glycine-
hydrazine buffer, pH 9.4, and incubated at 25uC for 30 minutes.
Changes in fluorescence due to NAD+ reduction were monitored.
Final concentrations in each spent culture droplet were deter-
mined against a six point standard curve from 0–1.0 mM lactate.
Determination of amino acid profiles
Spent and control droplets were diluted 1:12.5 in high
performance liquid chromatography (HPLC) grade water. Amino
acid concentrations in the droplets were determined by reverse-
phase HPLC as described previously [20,32]. Analysis was
performed on an Agilent 1100 automated HPLC system fitted
with a Phenomenex Hyperclone 5 mM C18 ODS 25064.6 mm
column (Phenomenex, Macclesfield, UK). A net fall in amino
acid concentration in the spent culture droplet was interpreted as
‘‘consumption’’; a net increase of an amino acid as ‘‘release’’. The
sum of consumption and production was used as an overall
indicator of amino acid metabolic activity and termed ‘‘turn-
over’’.
Prospective selection of viable embryos as a function of
pyruvate uptake on day 2
A further experiment focusing on embryo pyruvate consump-
tion on day 2 was carried out. On day 2, thirty embryos were
cultured individually for 24 hours for metabolic analysis. Pyruvate
uptake for each embryo was measured, and on day 3, the 30
embryos were allocated into tertiles on the basis of their pyruvate
consumption. Group 1 comprised 10 embryos with the lowest
measured values of pyruvate depletion; Group 2 comprised 10
embryos with intermediate pyruvate uptake whereas embryos
assigned to Group 3 had the 10 embryos with the highest pyruvate
uptake. This approach was chosen to avoid bias by ensuring that
final group sizes were all equal. The 3 groups of 10 embryos were
cultured from day 3 to day 8 and the rate of blastocyst
development on day 8 was recorded for each group. This
experiment was repeated 6 times.
Experimental design and Statistical analysis
Glucose and pyruvate consumption, production of lactate and
amino acid consumption/production/turnover by embryos are
expressed as pmol per embryo per hour 6 SEM. Embryos were
assayed at one developmental stage only in order to minimize the
stress of single culture. In the prospective studies, pyruvate alone
was measured in triplicate to provide additional confidence in the
results. Significant differences in metabolic profile (glucose, lactate
and pyruvate) were tested by Student’s t-test and one-way analysis
of variance (ANOVA) followed by Fisher’s LSD test post-hoc using
StatviewH (version 5.1). Following normality tests, amino acid data
were tested by Kruskal-Wallis tests followed by Mann-Whitney-U
tests post hoc since they were not normally distributed.
Results
Carbohydrate consumption/release throughout
development
Pyruvate and glucose uptake and lactate production were
recorded from individual in vitro-produced bovine embryos
throughout preimplantation development. An overall increase in
pyruvate and glucose uptake with development was observed
(Table 1). Pyruvate uptake was relatively constant up until the 5–
8 cell-stage then increased progressively until the expanded
blastocyst-stage. This rise was followed by a decrease at the time
of hatching to the level observed for early blastocysts. Glucose
consumption followed a broadly similar pattern with relatively low
consumption until the early blastocyst-stage. By contrast to
pyruvate, glucose uptake increased dramatically from early to
hatched blastocysts. Lactate production followed a similar pattern
to the uptake of glucose with a dramatic increase from the morula
stage.
Amino acid profile throughout development
The overall release of AA increased with development, from
4.7860.23 pmol/embryo/h for the 2–4 cell-stage to
40.2664.14 pmol/embryo/h for hatched blastocysts (p,0.05)
(Fig. 1A). Similarly, the overall consumption of AA increased with
development from 25.7260.35 pmol/embryo/h for 2–4 cell-
stage to 254.5767.71 pmol/embryo/h for hatched blastocysts
(p,0.05) (Fig. 1A). As a consequence, the turnover, which is the
sum of production and consumption of amino acid also increased
with development from 10.4960.39 pmol/embryo/h for 2–4 cell-
stage to 94.84611.64 for hatched blastocysts (p,0.05 (Fig. 1B).
The data from which these figures are drawn is included in Table
S1.
Metabolic analysis and morphological progression after
24 hours of individual culture
There was no difference in glucose depletion between cleavage-
stage embryos that progressed and those that did not during a
24 hr culture period. However, early and expanded blastocysts
that showed morphological changes after 24 hours of culture
consumed significantly higher levels of glucose (p = 0.0023 and
p,0.0001, respectively, Table 2). By contrast, differences in
lactate production between embryos with morphological progres-
sion were observed from the morula stage. Pyruvate uptake was
significantly higher for embryos with morphological progression at
all the stages of development measured in the present study. In
particular, 2–4 cell-stage embryos that progressed morphologically
had significantly higher pyruvate uptake than those which did not
progress (6.1960.66 vs. 3.8060.52 pmol/embryo/h, respectively,
p,0.05, Table 2)
The turnover of amino acids, which can be used as an overall
marker of amino acid metabolic activity was similar between
embryos with and without morphological changes at the early
stages within a 24 hr period (2–4 cells and 5–8 cells) (Table 2).
However, the turnover at later stages (morula, early and expanded
blastocysts) was significantly higher for embryos that subsequently
exhibited morphological changes in comparison with embryos
without morphological changes after 24 hours of culture. This
observation was mainly explained by an increase in amino acid
consumption at these stages for embryos with morphological
changes (Fig. 2A, 2B and 2C). The data from which these figures
are drawn are included in Table S2.
Embryo Metabolism and Viability
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Pyruvate consumption between day 2 and day 3 as a
prospective marker of ongoing development
Given that pyruvate depletion differed between embryos that
progressed morphologically after 24 hours of individual culture we
focused, in 6 independent experiments, on the relationship
between pyruvate consumption of day 2 cleaving embryos and
their ability to form a blastocyst on day 8. In each experiment,
thirty day 2 embryos were cultured individually for 24 hours from
day 2 to day 3. Then on day 3, embryos were grouped according
to the level of pyruvate uptake measured after 24 hours of individual
Table 1. The uptake of pyruvate and glucose and the production of lactate by individual bovine embryos produced in vitro.
Day of culture Stage
Pyruvate uptake
(pmol/embryo/h)
Glucose uptake
(pmol/embryo/h)
Lactate production
(pmol/embryo/h)
1–2 2–4 cells 5.0860.44a,b,c,d (88) 2.3360.26a,b,c,d (83) 1.6760.24a,b,c,d (118)
2–3 5–8 cells 5.4360.48e,f,g,h (74) 2.5960.37e,f,g (56) 3.6260.42e,f,g,h (106)
4–5 Morula 9.5160.89a,e,i,j,k,l (31) 7.2061.28a,h,i,j (32) 14.7261.20a,e,i,j,k (44)
5–6 Early blastocysts 16.4361.26b,f,i,j,m (54) 14.3161.14b,e,h,k,l (57) 23.6261.40b,f,i,l,m (74)
6–7 Expanded blastocysts 22.0361.02c,g,k,m,n (47) 34.2361.82c,f,i,k,m (85) 51.1262.39c,g,j,l,n (123)
7–8 Hatched blastocysts 16.7662.11d,h,l,n (26) 56.2962.91d,g,j,l,m (31) 85.9864.47d,h,k,m,n (46)
Number of samples are indicated in brackets.
Values with the same superscript in each column are significantly different (p,0.05).
doi:10.1371/journal.pone.0067834.t001
Figure 1. Amino acid production/consumption (A) and turnover (B) throughout preimplantation development by individual bovine
embryos produced in vitro. Turnover is the sum of amino acid consumption and production. Values with the same superscript are significantly
different (p,0.05).
doi:10.1371/journal.pone.0067834.g001
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culture, and returned to culture until day 8. The thirty embryos
were divided into 3 groups of ten embryos (low, medium and high
level of consumption). The embryos with intermediate level of
pyruvate uptake were associated with the highest number of cells on
day 2 (5.4360.16) and on day 3 (6.3760.20) (Table 3, Fig. 3). The
intermediate group was also associated with the highest rate of
blastocyst development on day 8 in comparison with the groups that
comprised embryos with low and high level of pyruvate uptake
(68.3% vs 13.3% and 25.0%, respectively, p,0.05).
Discussion
In this study, we report a detailed analysis of individual bovine
embryo metabolism, measuring a number of metabolic markers to
provide a comprehensive picture of substrate utilization in vitro. We
have generated these data by modifying the ultramicrofluoro-
metric method of Leese and Barton [26] to produce a high
throughput, simple spectrophotometric technique that could be
used in any laboratory with access to a plate reader with
fluorescence detection. Previously, only one study focused on the
analysis of the uptake of pyruvate and glucose and the production
of lactate by bovine embryos produced in vitro and incubated in
groups [33]. We chose this key data as the standard against which
to compare the data for individual embryos generated by our
modified, plate-reader based enzymatic assays. The results from
the present study broadly agree with those reported by Thompson
et al [33], suggesting that our refinement of the technique
generates robust data. However, in the present study, blastocysts
have been sub-categorised according to blastocoel development to
give a more detailed picture of metabolic activity throughout in
vitro development. Our data confirm that in bovine embryos,
pyruvate is consumed in preference to glucose in the early stages of
development before falling at the hatched blastocyst stage. Glucose
becomes the predominantly depleted substrate at the blastocyst
stage with a dramatic increase both in glucose uptake and lactate
production, during expansion and hatching. In our study, the
highest value of glucose uptake was observed for hatched
blastocysts (56 pmol/embryo/h); a value similar to that described
for human blastocysts (42 pmol/embryo/h) [34]. Similarly, the
rate of lactate production during hatching (86 pmol/embryo/h)
was comparable to the highest value observed on day 5.5 for
human blastocysts (95 pmol/embryo/h) [35]. It was notable that
the mean glucose uptake throughout development, and the mean
lactate production from the morula stage were approximately 2-
fold higher in our study compared to values reported by
Thompson et al [33]. Our results were obtained using a lactate-
free culture medium, whereas in the study of Thompson et al [33]
lactate was present at a concentration of 10 mM which may have
inhibited the conversion of glucose to lactate by glycolysis, as
suggested by Leese [36]. The high levels of lactate formed in the
later stages of development could be in preparation for the anoxic
environment that the embryo may encounter at implantation
[18,37,38].
During blastocyst expansion, more glucose was depleted than
could be accounted for by lactate appearance, suggesting that
glucose may be diverted away from aerobic glycolysis. The fate of
this glucose is unclear, however it is likely that it is either oxidized
completely via the TCA cycle or utilized in one of the other
glucose-consuming pathways such as the Pentose Phosphate
Pathway to provide biosynthetic precursors. This mirrors the
Table 2. Comparison of mean values of metabolites consumed or produced in culture media between embryos with or without
evidences of morphological changes after 24 hours of individual culture.
Metabolite Initial stage No morphological changes Morphological changes p
Pyruvate 2–4 cells 3.8060.52 (41) 6.1960.66 (47) 0.0062
uptake 5–8 cells 4.2660.54 (42) 6.9760.80 (32) 0.0048
(pmol/emb/h) Morula 6.9960.98 (17) 12.5761.15 (14) 0.0009
Early blastocysts 11.5361.47 (19) 19.0961.61 (35) 0.0031
Expanded blastocysts 19.2661.26 (22) 24.4761.41 (25) 0.0092
Glucose 2–4 cells 2.7660.44 (35) 2.3860.49 (28) 0.5660
uptake 5–8 cells 2.6260.61 (23) 2.5260.52 (18) 0.9035
(pmol/emb/h) Morula 6.2961.70 (20) 8.7161.93 (12) 0.3703
Early blastocysts 9.5461.36 (19) 16.7061.43 (38) 0.0023
Expanded blastocysts 25.6062.05 (37) 40.8862.42 (48) ,0.0001
Lactate 2–4 cells 1.2460.32 (50) 0.9460.22 (47) 0.4514
production 5–8 cells 4.3660.70 (39) 3.6060.67 (50) 0.4419
(pmol/emb/h) Morula 12.2861.53 (26) 18.2461.64 (18) 0.0128
Early blastocysts 16.8161.40 (24) 26.9061.80 (50) 0.0005
Expanded blastocysts 38.2163.00 (48) 59.3963.06 (75) ,0.0001
Amino acid 2–4 cells 10.3860.57 (25) 10.6260.55 (23) 0.7630
turnover 5–8 cells 12.7160.69 (21) 11.5060.64 (31) 0.2152
(pmol/emb/h) Morula 17.2560.92 (30) 24.6761.44 (18) ,0.0001
Early blastocysts 23.1961.34 (29) 35.2963.21 (21) 0.0003
Expanded blastocysts 47.5062.64 (36) 64.2863.71 (34) 0.0004
Number of samples analysed are indicated in brackets.
Amino acid turnover is the sum of consumption and production.
doi:10.1371/journal.pone.0067834.t002
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pattern seen in porcine embryos [39], but differs slightly from the
picture for human embryo metabolism [35].
In addition, the current study has measured the metabolism of a
mixture amino acids, again collecting data from single embryos
representing a variety of preimplantation developmental stages.
Amino acid metabolism, as indicated by both consumption and
release, increased throughout development especially during
blastocyst expansion and hatching. Somewhat surprisingly, there
was a net appearance of amino acids during blastocoel formation
whereas hatching was associated with a net depletion. There were
Figure 2. Amino acid production (A) and consumption (B) and balance (C) throughout preimplantation development by individual
bovine embryos produced in vitro. Comparison between embryos with or without morphological changes after 24 hours of
individual culture. Balance is the difference between amino acid consumption and production. * = p,0.05.
doi:10.1371/journal.pone.0067834.g002
Embryo Metabolism and Viability
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no differences in overall usage of individual amino acids between
early stage embryos (2–4c, 5–8c and morula) that developed
compared to those which did not develop during the 24 h assay
culture period. This is in agreement with our earlier work [40]
which found that amino acid metabolism was only predictive of
bovine embryo development at the zygote stage. A number of
differences were apparent at the blastocyst stage: for example,
early blastocysts that developed during the assay period consumed
more arginine and produced less leucine than those that did not
develop during the culture period. The observed differences in
amino acid metabolism by blastocysts that developed might
provide additive value in embryo selections if combined with
pyruvate consumption during cleavage (see below). Experiments to
test this proposition are ongoing.
It was of interest that the overall level of amino acid metabolism
at the blastocyst stage was slightly elevated compared to our
previous work on the bovine [40], although values for early stage
embryos in the two studies were broadly comparable. Differences
could be attributable to individual embryo variation, however it is
notable that the semen used in this study was from a different sire
to that in our previous work [40]. This raises the interesting
question of the degree to which embryo metabolism is influenced
by the sperm used for in vitro fertilisation. There are of course a
variety of other, if less likely, explanations for these differences,
including changes in protocols, illustrating that care should be
exercised when extrapolating data from different studies.
We feel that the novelty of the current work arises from
determining metabolic activity of individually cultured embryos by
a rapid process, minimizing the time that the embryos are cultured
singly. This has provided the opportunity to track ongoing
development and search retrospectively for links between devel-
opmental outcome and metabolic activity in the context of a range
of identifiable substrates. It is important to highlight that bovine
embryo in vitro development is compromised in single culture
systems. Of all the substrates measured (glucose, pyruvate, lactate
and 18 amino acids), the consumption of pyruvate differed most
strikingly and consistently between embryos that progressed
morphologically and those without morphological progression.
Differences in pyruvate depletion were consistently observed at all
stages examined, with embryos that completed a developmental
progression consuming more pyruvate than those that remained
developmentally static. This observation prompted us to ask
whether the pattern in which cleavage stage embryos depleted
pyruvate could predict the ability to generate a blastocyst.
In order to do this, embryos were divided prospectively into
three groups on the basis of whether they had ‘‘high’’
(13.0060.48 pmol/embryo/h) ‘‘Intermediate’’ (6.1460.27 pmol/
embryo/h) or ‘‘low’’ (1.14 pmol/embryo/h) pyruvate depletion on
day 2 of development. Using this approach, it was found that
embryos on day 2 of development with an ‘intermediate level’ of
pyruvate uptake had a 68% probability of reaching the blastocyst
stage in comparison with early embryos with a ‘low’ or ‘high’ level
of pyruvate uptake (13% and 25% respectively). In related work,
Conaghan et al., [17] showed that pyruvate uptake by individual
human embryos measured each 24 hours between day 1 and day
3 was significantly lower for embryos that implanted than for those
which failed to implant. Our data suggest that, at least for pyruvate
consumption, there is a middle ‘optimum’ range of depletion,
which correlates with high viability. By contrast, embryos with
elevated or reduced metabolism are developmentally compro-
mised. This conclusion is consistent with the data of Turner et al
[41] for pyruvate consumption by single human embryos
conceived by natural cycle IVF.
Figure 3. Individual values for pyruvate consumption by
bovine embryos assigned to tertiles on the basis of their
pyruvate consumption and the resultant blastocyst rates.
Tertile 1 (T1) are the cohort of embryos with low rates of pyruvate
consumption (1.1460.02 pmol/embryo/h); Tertile 2 (T2) are the
embryos with an ‘‘intermediate’’ (6.1460.27 pmol/embryo/h) level of
pyruvate consumption and Tertile 3 are the embryos with high
pyruvate consumption (13.0060.48 pmol/embryo/h). Categories of
activity, according to the Dynamic Energy Budget Theory are overlaid.
According to this theory, we propose that for any given substrate, there
is an optimum level of metabolism, and that this optimum varies
temporally to meet the demands of growth and development at each
stage. In the case of an early embryo, we propose that when exposed to
a challenge or stress, the resulting response will have an energy cost.
This cost may be met by an increase depletion of a given substrate to
fuel the additional activity, or indeed may lead to a partitioning of
substrates away from essential processes. In either case, a shift out of
the optimum range leads to the early embryo having a pejus
metabolism, indicating sub-viability. The early embryo in this stage of
metabolism may be able to rectify the stress and return to optimum
metabolism and continue development, however if further resources
are needed, the embryo may be further compromised as indicated by a
pessimism metabolic phenotype; in this case, very low or very high
metabolic activity indicative of sub viability.
doi:10.1371/journal.pone.0067834.g003
Table 3. Rate of blastocyst development according to the
level of pyruvate uptake measured between day 2 and day 3.
LOW
pyruvate
uptake
INTERMEDIATE
pyruvate uptake
HIGH
Pyruvate
uptake
n 60 60 60
Mean pyruvate uptake
(pmol/emb/h)
1.1460.20a 6.1460.27a 13.0060.48a
Nb cells (Day 2) 4.4860.18a 5.4360.16a,b 4.8060.18b
Nb cells (Day 3) 5.1560.21a 6.3760.20a 5.8060.17a
Blastocyst rate (Day 8) 8/60 41/60 15/60
13.3%a 68.33%a,b 25.0%b
Values with the same superscript in each row are significantly different
(p,0.05).
Data from 6 independent experiments including 30 embryos for each.
All stages (early, expanded and hatched) have been included to define the
blastocyst rate.
doi:10.1371/journal.pone.0067834.t003
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These data suggest that embryo metabolic activity relates to
ongoing developmental capacity and offer an opportunity to revisit
the notion of a unifying framework to describe the relationship
between metabolic activity and early development. One such
framework is offered by the ‘‘Quiet Embryo Hypothesis’’ [22]. In
summary, the Quiet Embryo Hypothesis, states that embryo
viability is best served by a low metabolic activity that falls within a
low range that can be termed ‘quiet’; the corollary states that an
‘active’ or ‘noisy’ metabolism is indicative of embryos requiring
higher nutrient inputs and consequently having to expend extra
energy, most likely required to carry out repair processes to reach
the same developmental endpoint. This idea was developed by
Leese et al [42] who proposed that the ‘concept of quiet
metabolism is not about ’one size fits all’ but rather that, for any
given set of circumstances there is an optimal range of embryonic
activity consistent with successful developmental progression. The
current data support this idea that there is an ‘optimum range’ of
metabolic activity that relates to a minimal input to carry out
developmental milestone events; below this threshold, the embryo
will have insufficient metabolic activity to support development
while activity of a given metabolic pathway above a given
threshold may be indicative of a stressed embryo that is ‘working
harder;’ to maintain its developmental trajectory. This notion is
well-accommodated in the Dynamic Energy Budget scheme of
Kooijman [43], which is a universal ecological concept that
describes metabolism sufficient to meet the needs for maintenance
and growth at any given stage of development in terms of an
‘‘optimum range’’, and of ranges higher and lower than optimum,
which, in the nomenclature of the Dynamic Energy Budget
Theory, are referred to as ‘pejus’ and ‘pessimum’ ranges. In a state
of ‘‘pejus’’, there is still scope for demands to be met, but at a cost to
growth/development, due to an increased metabolic burden
required to respond to a stress. In the case of the early embryo,
such a response could include early activation of the genome,
repair of cellular damage, degradation of damaged blastomeres,
amongst other possible processes; each will lead to a rise in energy
metabolism and/or a potential partitioning of substrates away
from other essential homeostatic processes, or a reduced ability to
supply nutrients (i.e. insufficient metabolism). Alternatively, if an
embryo is severely compromised, the ‘‘pejus’’ metabolism might be
low, and sufficient for one or two cleavages, possibly reliant on
endogenous energy reserves, but below the threshold required to
sustain development to a blastocyst and beyond. Metabolic activity
below or above the optimum therefore places the embryo in a
compromised metabolic state (Fig. 3). Metabolic activity is
necessarily dynamic and may not be fixed. As a consequence, in
the case of a stressed embryo with a compromised metabolism, if
the stress is rectified, the embryo may escape from the ‘‘pejus’’
range and return to the optimum range to continue its
development. In other individual cases, the cognate increase in
metabolic energy to meet rising demand will lead to an increase in
substrate depletion, increased overall metabolic activity, and the
appearance of a hyperactive metabolism leading to a state of pessimism
(from the Latin for ‘‘the worst’’). Examples of this might include a
loss of metabolic regulation and subsequent degeneration most
likely arising from damage to mitochondria or loss of REDOX
regulation; the consequence is a drop to insufficient metabolic
activity and ultimate degeneration.
In conclusion, we propose that the idea of a dynamic energy
budget with an optimal range of metabolic activity provides an
attractive evolution of the Quiet Embryo Hypothesis. The
common thread is that metabolic homeostasis and restraint are
conducive to development, and an embryo developing with a high
degree of fidelity and low requirement for additional resources will
be a low-input system with a metabolism that is optimised to meet
requirements. We feel that our present data, combined with the
findings of Conaghan et al [17] and Turner et al [41] which
proposed a link between pyruvate metabolism and human embryo
viability, and a reanalysis of the relationship between metabolism
and viability make a strong case for revisiting pyruvate depletion as
a biomarker of embryo viability, particularly given the availability
of a rapid, high-throughput simple technique for the assay of
single-substrate consumption.
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